Condition: Low-grade NMIBC · FGFR Gene Amplification · FGFR Gene Alterations · Sponsor: Tyra Biosciences, Inc
Phase 2 Study of TYRA-300 in FGFR3 Altered Low Grade, Intermediate Risk NMIBC
This description comes directly from the study's public registry record.
Grace Indyk · 858-356-2323 · TyraClinicalTrials@tyra.bio
Always discuss trial participation with your own doctor first.
| Urology Centers of Alabama | Homewood, Alabama, United States | Recruiting |
| Arkansas Urology | Little Rock, Arkansas, United States | Recruiting |
| Tri Valley Urology - Murrieta | Murrieta, California, United States | Recruiting |
| Eisenhower Medical Associates | Rancho Mirage, California, United States | Recruiting |
| Om Research LLC | San Diego, California, United States | Recruiting |
| Associated Urological Specialists | Chicago Ridge, Illinois, United States | Recruiting |
| Duly Health and Care | Lisle, Illinois, United States | Recruiting |
| Urology of Indiana | Greenwood, Indiana, United States | Recruiting |
| First Urology | Jeffersonville, Indiana, United States | Recruiting |
| University of Kansas Medical Center (KUMC) | Kansas City, Kansas, United States | Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| Greater Boston Urology | Plymouth, Massachusetts, United States | Recruiting |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06995677